Frontline brentuximab vedotin as monotherapy or in combination for older Hodgkin lymphoma patients.Christopher A. Yasenchak, Jonathan W. Friedberg, Dipti Patel‐Donnelly et al.|Journal of Clinical Oncology|2020Cited by 3